\relax 
\providecommand\hyper@newdestlabel[2]{}
\providecommand\zref@newlabel[2]{}
\providecommand\babel@aux[2]{}
\@nameuse{bbl@beforestart}
\catcode `:\active 
\catcode `;\active 
\catcode `!\active 
\catcode `?\active 
\providecommand\HyperFirstAtBeginDocument{\AtBeginDocument}
\HyperFirstAtBeginDocument{\ifx\hyper@anchor\@undefined
\global\let\oldcontentsline\contentsline
\gdef\contentsline#1#2#3#4{\oldcontentsline{#1}{#2}{#3}}
\global\let\oldnewlabel\newlabel
\gdef\newlabel#1#2{\newlabelxx{#1}#2}
\gdef\newlabelxx#1#2#3#4#5#6{\oldnewlabel{#1}{{#2}{#3}}}
\AtEndDocument{\ifx\hyper@anchor\@undefined
\let\contentsline\oldcontentsline
\let\newlabel\oldnewlabel
\fi}
\fi}
\global\let\hyper@last\relax 
\gdef\HyperFirstAtBeginDocument#1{#1}
\providecommand\HyField@AuxAddToFields[1]{}
\providecommand\HyField@AuxAddToCoFields[2]{}
\providecommand\pbs@newkey[2]{}
\providecommand\pbs@seq@push@cx[2]{}
\providecommand\@anim@newkey[2]{}
\bibstyle{biblatex}
\bibdata{2026-FicheResolution-blx,SAE31}
\citation{biblatex-control}
\abx@aux@refcontext{nyt/global//global/global}
\citation{saito_innate_2008}
\abx@aux@cite{0}{saito_innate_2008}
\abx@aux@segm{0}{0}{saito_innate_2008}
\gdef \LT@i {\LT@entry 
    {2}{140.83739pt}\LT@entry 
    {2}{339.60667pt}}
\babel@aux{french}{}
\@writefile{toc}{\contentsline {section}{\numberline {0.1}Stratégies des cellules infectées pour reconnaître le virus de l'hépatite C (HCV)}{1}{section.0.1}\protected@file@percent }
\abx@aux@page{1}{1}
\@writefile{toc}{\contentsline {section}{\numberline {0.2}Références}{2}{section.0.2}\protected@file@percent }
\abx@aux@page{2}{2}
\citation{chigbu_hepatitis_2019}
\abx@aux@cite{0}{chigbu_hepatitis_2019}
\abx@aux@segm{0}{0}{chigbu_hepatitis_2019}
\@writefile{toc}{\contentsline {section}{\numberline {0.3}Figure Bilan}{3}{section.0.3}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1}{\ignorespaces  "A host immune response to an HCV infection: The interaction between HCV and hepatocytes induces innate and adaptive immune responses. During an HCV infection of hepatocytes, HCV RNA engages TLR3, RIG-I, and MDA5 on infected hepatocytes as well as TLR7 on pDC to induce the secretion of type I and III interferons. Type I and III IFN inhibit HCV replication and activate NK cells. Activated NK cells produce IFN$-\gamma $ and TNF$\alpha $, which induce DC maturation and inhibit HCV replication. Matured DC produce IL-12 that induce the differentiation of CD4 T cells and CD8 T cells into Th1 cells and Cytotoxic T cells, respectively. Additionally, IL-12 and IL-15 secreted by DC activate NK cells. Th1 cells secrete IL-2, IFN$-\gamma $, and TNF$\alpha $. IL-2 induce the proliferation of CD8 T cells, whereas IFN-γ and TNF$\alpha $ inhibit HCV replication without inducing a cytolysis of HCV-infected cells. Furthermore, IFN$-\gamma $ produced by Th1 cell induce the differentiation of B cells into plasma cells that produce neutralizing antibodies. Finally, perforin and granzyme B produced by CTL and activated NK cells induce the cytolysis of HCV-infected cells."\relax }}{3}{figure.caption.1}\protected@file@percent }
\abx@aux@read@bbl@mdfivesum{44934A0C2DA793D99951F166D7523ECE}
\abx@aux@defaultrefcontext{0}{saito_innate_2008}{nyt/global//global/global}
\abx@aux@defaultlabelprefix{0}{saito_innate_2008}{}
\gdef \@abspage@last{3}